As shown in Fig. 5c, glioblastoma cells treated with the compound-1H led to an elevation of apoptosis-related proteins (Bax, cleaved caspase-3, cleaved caspase-9 and cleaved PARP), while Bcl-2 was down-regulated in a dose-dependent manner. Here, BCL2 is linked to glioblastoma.